DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical Preparations
DYN

DYNE THERAPEUTICS INC

241 institutions still hold DYNE THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 26818M108·Pharmaceutical Preparations·241 13F holders·last filed Mar 31, 2026
Market cap
13F value held
$2.5B
visible holders
Holders
241
filers reporting
Concentration
22.54%
T. Rowe Price Investment Management, Inc. #1
top holder share
AI Holders Summary · Q1 2026

241 institutions reported DYN in Q1 2026. T. Rowe Price Investment Management, Inc. leads at 22.5% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
T. Rowe Price Investment Management, Inc.
CIK 0001897612
$558M30.8M0.38%Q1 2026
02
JANUS HENDERSON GROUP PLC
CIK 0001274173
$247M13.6M0.12%Q1 2026
03
BlackRock, Inc.
CIK 0002012383
$212M11.7M0.00%Q1 2026
04
Atlas Venture Life Science Advisors, LLC
CIK 0001917529
$166M9.1M20.95%Q1 2026
05
FMR LLC
CIK 0000315066
$162M8.9M0.01%Q1 2026
06
Orbis Allan Gray Ltd
CIK 0001663865
$123M6.8M0.52%Q1 2026
07
STATE STREET CORP
CIK 0000093751
$121M6.7M0.00%Q1 2026
08
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$116M6.4M0.00%Q1 2026
09
PERCEPTIVE ADVISORS LLC
CIK 0001224962
$85M4.7M1.65%Q1 2026
10
FCPM III SERVICES B.V.
CIK 0002013410
$84M4.6M11.66%Q1 2026
11
TCG Crossover Management, LLC
CIK 0001839948
$84M4.6M2.39%Q1 2026
12
Vanguard Portfolio Management
CIK 0002100121· Index
$75M4.2M0.00%Q1 2026
13
Vestal Point Capital, LP
CIK 0001974915
$73M4.0M2.03%Q1 2026
14
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$64M3.5M0.00%Q1 2026
15
ARMISTICE CAPITAL, LLC
CIK 0001601086
$58M3.2M1.02%Q1 2026
16
Frazier Life Sciences Management, L.P.
CIK 0001892134
$57M3.2M1.47%Q1 2026
17
JPMORGAN CHASE & CO
CIK 0000019617
$56M3.3M0.00%Q1 2026
18
ORBIMED ADVISORS LLC
CIK 0001055951
$53M2.9M1.05%Q1 2026
19
VR Adviser, LLC
CIK 0001615982
$43M2.2M2.10%Q4 2025
20
PRICE T ROWE ASSOCIATES INC /MD/
CIK 0000080255
$42M2.3M0.00%Q1 2026
Page 1 of 13
221 more holders available. Log in →
Insiders at DYNE THERAPEUTICS INC
Rhodes Jason PGreene Barry ECox JohnFriedl-Naderer JohannaKerr DouglasPosner Brian SLubner David CharlesHurwitz Edward